These stocks made big moves today 📈

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome to the Closing Bell Roundup. Please, feel free to reply to this email and tell us what you think of this new addition to the Elite Trade Club lineup! Today is Thursday, November 3rd. I hope you had a great day! Here's what moved the market today: Markets 📈 US indexes carried losses for the trading day, but most managed to close slightly higher than their intraday lows. The S&P 500 [-1.0%], Nasdaq [-1.7%], and Dow [-0.4%] closed, as did the small-cap Russell 2K [-0.2%]. Sthttps:// with 200elitetra.de/JO7z Sponsored [Get Your Money Out of U.S. Banks Immediately]( A historic financial reset in 2023 could soon result in a run on the banks. Get out of cash and into a new vehicle 50 years in the making. [MORE HERE]( Today's Market-Moving News 🔎 - BOE Hike: The Bank of England announced a 0.75% interest rate hike today, matching the recently-announced increase from its U.S. counterpart, the Federal Reserve. - Mortgage Rates Fall: The average rate on a 30-yeard fixed mortgage sank to 6.95% today, after hitting 7.08% last week. Today's Top Winners and Losers 🔥 Vapotherm Inc [VAPO] $1.26 (-40.2%) Disappointing Q3 earnings sent VAPO tumbling in today's session. Revenues of $13.5 million missed the Street's $16.54 million target, and the firm also posted a wider-than-expected loss of $(0.98) per share. Peak Bio [PKBO] $3.80 (-45.5%) Peak Bio has seen sharp declines since completing its business combination with Ignyte Acquisition Corp SPAC. Shares plummeted in their market debut on Wednesday, and the declines continued in today's trading session. Surgalign Holdings [SRGA ://elitetra.de/L2Ic ] $2.00 (-35.0%) Surgalign's Q3 revenues and earnings disappointed Wall Street's estimates, and the company also lowered its full-year 2022 sales guidance in response to the weak quarter. The company posted a loss of $(1.46) per share on revenues of $20.2 million, marking a decline from the year-earlier quarter's $20.5 million top-line figure. Nerdwallet Inc [NRDS] $13.63 (+37.4%) Nerdwallet's generated EPS of $0.01 per share on revenues of $142.6 million in its Q3 earnings release, and beat analysts' estimates by a wide margin. The consensus target called for a loss of -$(0.13) per share on revenues of $135.3 million. Nerdwallet's Q4 guidance was also better than expected. Virax Biolabs Group Ltd [VRAX] $2.29 (+36.3%) Virax soared today after announcing the launch of a new three-in-one rapid test kit for RSV, COVID, and influenza. We featured VRAX in our morning report with a 22.6% gain, and the stock added to its gains during the trading session. Provention Bio Inc [PRVB] $8.41 (+26.0%) Provention Bio reported a quarterly loss of -$(0.34) per share on its Q3 earnings release to beat analysts' -$(0.42) EPS target by 19.0%. It also announced it is in advanced preparations for a potential U.S. commercial launch of teplizumab ahead of the FDA user fee goal date of Nov. 17th. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](